Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 23:9:35501-35513.
doi: 10.1109/ACCESS.2021.3061621. eCollection 2021.

Detecting SARS-CoV-2 From Chest X-Ray Using Artificial Intelligence

Affiliations

Detecting SARS-CoV-2 From Chest X-Ray Using Artificial Intelligence

Md Manjurul Ahsan et al. IEEE Access. .

Abstract

Chest radiographs (X-rays) combined with Deep Convolutional Neural Network (CNN) methods have been demonstrated to detect and diagnose the onset of COVID-19, the disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). However, questions remain regarding the accuracy of those methods as they are often challenged by limited datasets, performance legitimacy on imbalanced data, and have their results typically reported without proper confidence intervals. Considering the opportunity to address these issues, in this study, we propose and test six modified deep learning models, including VGG16, InceptionResNetV2, ResNet50, MobileNetV2, ResNet101, and VGG19 to detect SARS-CoV-2 infection from chest X-ray images. Results are evaluated in terms of accuracy, precision, recall, and f- score using a small and balanced dataset (Study One), and a larger and imbalanced dataset (Study Two). With 95% confidence interval, VGG16 and MobileNetV2 show that, on both datasets, the model could identify patients with COVID-19 symptoms with an accuracy of up to 100%. We also present a pilot test of VGG16 models on a multi-class dataset, showing promising results by achieving 91% accuracy in detecting COVID-19, normal, and Pneumonia patients. Furthermore, we demonstrated that poorly performing models in Study One (ResNet50 and ResNet101) had their accuracy rise from 70% to 93% once trained with the comparatively larger dataset of Study Two. Still, models like InceptionResNetV2 and VGG19's demonstrated an accuracy of 97% on both datasets, which posits the effectiveness of our proposed methods, ultimately presenting a reasonable and accessible alternative to identify patients with COVID-19.

Keywords: Artificial intelligence; COVID-19; SARS-CoV-2; chest X-ray; coronavirus; deep learning; imbalanced data; small data.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Representative samples of chest X-ray images from the open source data repositories used in our proposed studies.
FIGURE 2.
FIGURE 2.
Modified architecture with new classifier .
FIGURE 3.
FIGURE 3.
VGG16 architecture used during this experiment.
FIGURE 4.
FIGURE 4.
Study one confusion matrices for six different deep learning models applied on the test set.
FIGURE 5.
FIGURE 5.
Training and validation accuracy throughout the execution of each model in study one.
FIGURE 6.
FIGURE 6.
Training and validation loss throughout the execution of each model in study one.
FIGURE 7.
FIGURE 7.
Study two confusion matrices for six different deep learning models applied on the test set.
FIGURE 8.
FIGURE 8.
Training and validation accuracy throughout the execution of each model in study two.
FIGURE 9.
FIGURE 9.
Training and validation loss throughout the execution of each model in study two.
FIGURE 10.
FIGURE 10.
Heatmap of class activation on different layers.
FIGURE 11.
FIGURE 11.
Model’s ability to identify important features on chest X-ray using VGG16.
FIGURE 12.
FIGURE 12.
Model’s competency to identify essential features on chest X-ray using MobileNetV2.

Similar articles

Cited by

References

    1. Worldometer. COVID-19 World Meter. Accessed: Aug. 6, 2020. [Online]. Available: https://www.worldometers.info/coronavirus
    1. Rothan H. A. and Byrareddy S. N., “The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak,” J. Autoimmunity, vol. 109, May 2020, Art. no. 102433, doi: 10.1016/j.jaut.2020.102433. - DOI - PMC - PubMed
    1. Pan L., Mu M., Yang P., Sun Y., Wang R., Yan J., Li P., Hu B., Wang J., Hu C., Jin Y., Niu X., Ping R., Du Y., Li T., Xu G., Hu Q., and Tu L., “Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: A descriptive, cross-sectional, multicenter study,” Amer. J. Gastroenterol., vol. 115, no. 5, pp. 766–773, May 2020, doi: 10.14309/ajg.0000000000000620. - DOI - PMC - PubMed
    1. Shen M., Zhou Y., Ye J., AL-Maskri A. A., Kang Y., Zeng S., and Cai S., “Recent advances and perspectives of nucleic acid detection for coronavirus,” J. Pharmaceutical Anal., vol. 10, no. 2, pp. 97–101, Apr. 2020, doi: 10.1016/j.jpha.2020.02.010. - DOI - PMC - PubMed
    1. Tahamtan A. and Ardebili A., “Real-time RT-PCR in COVID-19 detection: Issues affecting the results,” Expert Rev. Mol. Diag., vol. 20, no. 5, pp. 453–454, Apr. 2020, doi: 10.1080/14737159.2020.1757437. - DOI - PMC - PubMed

LinkOut - more resources